Generic medicine
Dihydroartemisinin + Piperaquine
Dihydroartemisinin + Piperaquine · Anti-infectives · Antimalarials
Data statusRegistration & price fields require source verification.
25brands/products
16companies
25with current prices
Available dosage forms
Tap a form to filter the brand listChoose a form
Pakistan brand index
Available brands
| Brand | Manufacturer | Strength | Form | Pack | Reg. no. | Official price | Unit price |
|---|---|---|---|---|---|---|---|
| ARTEQUINE | Platinum Pharmaceuticals | 40 mg + 320 mg | Tablet | 8'S | 061468 | PKR 698.392026-07-23 | PKR 87.30/ tablet |
| Dimisinex | Nexus Pharma (Pvt) Ltd | 320 mg + 320 mg | Tablet | 8's | 075835 | PKR 743.322025-10-21 | PKR 92.92/ tablet |
| Diphos | M/s. Genix Pharma (Pvt) Ltd. | 40 mg + 320 mg | Tablet | 9's | 061249 | PKR 760.052026-07-23 | PKR 84.45/ tablet |
| Diphos | M/s. Genix Pharma (Pvt) Ltd. | 40 mg + 320 mg | Tablet | 18's | 061249 | PKR 1,444.712026-07-23 | PKR 80.26/ tablet |
| Diphos | M/s. Genix Pharma (Pvt) Ltd. | 40 mg + 320 mg | Tablet | 8's | 061249 | PKR 644.272026-07-23 | PKR 80.53/ tablet |
| DIPIP | Hilton Pharma (Pvt) Limited. | 40 mg + 320 mg | Tablet | 8's | 076168 | PKR 627.912026-07-27 | PKR 78.49/ tablet |
| EUARIA | Martin Dow Limited | 40 mg + 320 mg | Tablet | 8's | 079618 | PKR 676.332026-07-22 | PKR 84.54/ tablet |
| Hedqin 40 | M/s Daneen Pharma (Pvt) Ltd | 40 mg + 320 mg | Tablet | 8's | 109415 | PKR 676.292026-07-22 | PKR 84.54/ tablet |
| Hitecxin ACT | Highnoon Laboratories Ltd | 40 mg + 320 mg | Tablet | 8 | 044767 | PKR 749.012026-07-27 | PKR 93.63/ tablet |
| Maldip | Aspin Pharma | 40 mg + 320 mg | Tablet | 8's | 100142 | PKR 670.672026-07-23 | PKR 83.83/ tablet |
| PIPRA | Atco Laboratories Limited | 40 mg + 320 mg | Tablet | 8's | 073874 | PKR 680.222026-07-23 | PKR 85.03/ tablet |
| Tess 40 | Hiranis Pharmaceuticals Pvt. Ltd. | 40 mg + 320 mg | Tablet | 8's | 083757 | PKR 676.252026-07-22 | PKR 84.53/ tablet |
Independent editorial layer
Medicine information
Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.